Psychedelics help compulsive thinking, like craving in drug addiction | Wim Van Den Brink, MD, PhD скачать в хорошем качестве

Psychedelics help compulsive thinking, like craving in drug addiction | Wim Van Den Brink, MD, PhD

Interview with Wim van den Brink, MD, PhD, Professor of Psychiatry & Addiction, Academic Medical Center, University of Amsterdam, The Netherlands and board member of the OPEN Foundation. Learn more: https://open-foundation.org/ Filmed at the Interdisciplinary Conference on Psychedelic Research (ICPR) 2024 in Haarlem, The Netherlands. Learn more: https://www.icpr-conference.com/ OPEN Minded Newsletter readers stay informed about the latest research, news, and updates in the field of psychedelic research and therapy. Join 10.000+ of us: https://open-foundation.org/newsletter/ Questions: 00:00 Intro 00:05 How did you get involved as a researcher in studying psychedelics? 01:24 Some people say that psychedelics are one of the first new major innovations since the 70s in Psychiatry. How do you see that? 03:07 Psychedelic treatment is a hybrid between talking therapy and psychopharmacological treatment. How is it different from traditional forms of treatment? 05:53 What is the neuro biological mechanism that explains why psychedelics are so effective in treatment? 10:16 Psychedelics don't work for everyone. Do we have any idea for whom they work and for whom they don't work? 13:45 Do psychedelics have a potential to treat addiction? 16:05 Clinical treatment has very strict rules and limitations. But people have been using psychedelics in other non-medical settings in groups, in the nature. Do you think that we can combine those methods with clinical treatment? 17:53 Some people say that we move too fast. And, there is, risk of, backlash. How do you see that risk? 18:55 You talked about retreats. As far as I know there are many retreats in the Netherlands. How are they regulated? 20:48 What is the situation with MDMA treatment in the Netherlands? 22:06 The costs of psychedelic treatment are very high. How can we make sure that they are accessible to less wealthy people as well? 24:20 How do you see the role of harm reduction in the psychedelic field? 26:09 How do you see the future of psychedelics? Will they be part of the mainstream medical care? And do they have room outside of the medical realm? Stay tuned   / open.fndn     / icpr_conference     / open-foundation      / @openfoundationicpr     / open_fndn   https://www.drugreporter.net   / drugreporter   Reporter: Péter Sárosi | Rights Reporter Foundation - Drugreporter Camera and editing: István Gábor Takács | Rights Reporter Foundation - Drugreporter ---------------------------------------------------------------------------------------------------------------------